Ati cautat: evaluarea riscului de diabet

Protocol terapeutic: A10BX10 – DCI LIXISENATIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: B01AE07 – DCI DABIGATRANUM ETEXILATUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: A10BH03 – DCI SAXAGLIPTINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: L002G – DCI TRATAMENT IMUNOMODULATOR – SCLEROZĂ MULTIPLĂ (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)

Protocol terapeutic: H005E – ACROMEGALIE ŞI GIGANTISM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: C008N – DCI IRBESARTANUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)

Protocol terapeutic: C004I – DCI ACID OMEGA-3-ESTERI ETILICI (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)